Results 171 to 180 of about 4,714 (209)
Some of the next articles are maybe not open access.
Dydrogesterone and pre-term birth
Hormone Molecular Biology and Clinical Investigation, 2016Abstract Progestin supplementation appears to be a promising approach to both preventing initiation of pre-term labor and treating it once it is already established. Successful pregnancy depends on maternal tolerance of the fetal “semi-allograft”.
Hudic, Igor +3 more
openaire +2 more sources
Takotsubo cardiomyopathy associated with dydrogesterone use
BMJ Case Reports, 2021Takotsubo cardiomyopathy is characterised by left ventricular apical ballooning, in the absence of coronary artery disease, and classically occurs at times of intense stress. Due to the striking preponderance of Takotsubo cardiomyopathy occurring in postmenopausal women, it has been postulated that female sex hormones may also be implicated in its ...
openaire +2 more sources
Dydrogesterone in threatened abortion: Pregnancy outcome
The Journal of Steroid Biochemistry and Molecular Biology, 2005To determine whether therapy with dydrogesterone in threatened abortion during the first trimester of pregnancy will improve pregnancy outcome.Prospective open study.Pregnant women presenting to the obstetric and gynaecology clinic admitting center with vaginal bleeding before 13 weeks gestation were evaluated for entry into the study.
M H, Omar +3 more
openaire +2 more sources
Dydrogesterone and the immunology of pregnancy
Hormone Molecular Biology and Clinical Investigation, 2016Abstract Progesterone is indispensable for the maintenance of pregnancy, both via its endocrine effects and its role in creating a favorable immunological environment for the fetus. This review focuses on the immunological effects of progesterone.
Raj, Raghupathy, Julia, Szekeres-Bartho
openaire +2 more sources
Dydrogesterone (duphaston) for dysmenorrhoea
Drug and Therapeutics Bulletin, 1968Dydrogesterone (Duphaston-Crookes) is a progestagen which produces the effects of progesterone on the uterus, but has much weaker central effects than do other progestagens. Thus dydrogesterone does not raise the basal body temperature and only slightly inhibits the pituitary.1 We discussed the drug when it was introduced in 1962.2
openaire +1 more source
Dydrogesterone in threatened miscarriage: A Malaysian experience
Maturitas, 2009Threatened miscarriage is a common problem during pregnancy.The aim of this prospective, open, randomised study was to determine whether dydrogesterone was more effective than conservative management alone in preventing miscarriage in women with vaginal bleeding up to week 16 of pregnancy.
openaire +2 more sources